Wells Fargo
IMUX icon

Wells Fargo’s Immunic IMUX Stock Holding History

Wells Fargo’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$999 Hold
90
– – ﹤0.01% 6334
2025
Q4 		$480 Sell
90
-15
-14% -$110 ﹤0.01% 6337
2025
Q3 		$923 Hold
105
– – ﹤0.01% 6263
2025
Q2 		$730 Buy
105
+85
+425% +$780 ﹤0.01% 6341
2025
Q1 		$214 Hold
20
– – ﹤0.01% 6327
2024
Q4 		$197 Hold
20
– – ﹤0.01% 6363
2024
Q3 		$325 Sell
20
-25
-56% -$356 ﹤0.01% 6199
2024
Q2 		$496 Sell
45
-53
-54% -$658 ﹤0.01% 6148
2024
Q1 		$1.29K Buy
98
+39
+66% +$507 ﹤0.01% 6096
2023
Q4 		$887 Buy
59
+2
+4% +$25 ﹤0.01% 6258
2023
Q3 		$845 Buy
57
+6
+12% +$115 ﹤0.01% 6238
2023
Q2 		$1.28K Buy
51
+1
+2% +$17 ﹤0.01% 6279
2023
Q1 		$743 Buy
50
+3
+6% +$56 ﹤0.01% 6457
2022
Q4 		$654 Buy
47
+6
+15% +$164 ﹤0.01% 6313
2022
Q3 		$2K Sell
41
-6
-13% -$251 ﹤0.01% 6157
2022
Q2 		$2K Sell
47
-105
-69% -$6.73K ﹤0.01% 6330
2022
Q1 		$17K Sell
152
-675
-82% -$78.1K ﹤0.01% 6076
2021
Q4 		$79K Buy
827
+801
+3,081% +$72.1K ﹤0.01% 5752
2021
Q3 		$2K Sell
26
-2
-7% -$197 ﹤0.01% 6573
2021
Q2 		$3K Sell
28
-40
-59% -$5.53K ﹤0.01% 6460
2021
Q1 		$10K Sell
68
-2,517
-97% -$427K ﹤0.01% 6336
2020
Q4 		$395K Buy
2,585
+591
+30% +$106K ﹤0.01% 4694
2020
Q3 		$371K Buy
1,994
+207
+12% +$33.9K ﹤0.01% 4564
2020
Q2 		$216K Buy
1,787
+706
+65% +$71.8K ﹤0.01% 4867
2020
Q1 		$65K Buy
1,081
+476
+79% +$38.3K ﹤0.01% 5251
2019
Q4 		$59K Buy
605
+603
+30,150% +$50.1K ﹤0.01% 5463
2019
Q3 		$0 Sell
2
-3
-60% -$402 ﹤0.01% 6534
2019
Q2 		$0 Sell
5
-8
-62% -$1.05K ﹤0.01% 6483
2019
Q1 		$1K Hold
13
– – ﹤0.01% 5938
2018
Q4 		$1K Hold
13
– – ﹤0.01% 6279
2018
Q3 		$1K Buy
13
+2
+18% +$5.22K ﹤0.01% 6302
2018
Q2 		$31K Buy
11
+9
+450% +$20.8K ﹤0.01% 5726
2018
Q1 		$5K Hold
2
– – ﹤0.01% 6060
2017
Q4 		$4K Buy
+2
New +$4.42K ﹤0.01% 6085
2017
Q2 		– Sell
-40
Closed -$64K – 6329
2017
Q1 		$64K Hold
40
– – ﹤0.01% 5364
2016
Q4 		$70K Buy
40
+20
+100% +$43.8K ﹤0.01% 5287
2016
Q3 		$49K Hold
20
– – ﹤0.01% 5294
2016
Q2 		$50K Sell
20
-2
-9% -$6.57K ﹤0.01% 5200
2016
Q1 		$79K Buy
22
+2
+10% +$6.95K ﹤0.01% 5002
2015
Q4 		$93K Hold
20
– – ﹤0.01% 4959
2015
Q3 		$33K Buy
20
+18
+900% +$90.1K ﹤0.01% 5392
2015
Q2 		$18K Sell
2
-11
-85% -$105K ﹤0.01% 5633
2015
Q1 		$134K Buy
13
+12
+1,200% +$110K ﹤0.01% 4622
2014
Q4 		$6K Hold
1
– – ﹤0.01% 5805
2014
Q3 		$5K Hold
1
– – ﹤0.01% 5816
2014
Q2 		$10K Buy
+1
New +$7.02K ﹤0.01% 5637

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Wells Fargo's IMUX Position: Q1 2026 in Review

Wells Fargo held its Immunic (IMUX) position steady in Q1 2026 at 90 shares worth $999. The position accounts for ﹤0.01% of the portfolio, ranked #6334.

Wells Fargo first reported a position in IMUX in Q2 2014 and has held it in 46 quarters since. The position peaked at $395K in Q4 2020. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Wells Fargo held 90 shares of Immunic worth $999 as of Q1 2026.
  • Wells Fargo left its Immunic share count unchanged in Q1 2026.
  • Immunic made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6334 holding.
  • Wells Fargo first reported a position in Immunic in Q2 2014 and has held it in 46 quarters since.
  • Wells Fargo's Immunic position peaked at $395K in Q4 2020.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.